{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T02:09:26Z","timestamp":1775873366963,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54DK083912"],"award-info":[{"award-number":["U54DK083912"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016650","name":"Rare Diseases Clinical Research Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019337","name":"Miami Clinical and Translational Science Institute, University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U2CTR002818"],"award-info":[{"award-number":["U2CTR002818"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019452","name":"Halpin Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002736"],"award-info":[{"award-number":["UL1TR002736"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020652","name":"Nephrotic Syndrome Study Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ekir.2023.01.031","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T21:11:54Z","timestamp":1675458714000},"page":"884-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Identification of Glomerular and Plasma Apolipoprotein M as Novel Biomarkers in Glomerular Disease"],"prefix":"10.1016","volume":"8","author":[{"given":"Yelena","family":"Drexler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tali","family":"Elfassy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Christoffersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kurano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Yatomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura H.","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Merscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Fornoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2023.01.031_bib1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2215\/CJN.10871016","article-title":"Temporal and demographic trends in glomerular disease epidemiology in the Southeastern United States, 1986\u20132015","volume":"12","author":"O\u2019Shaughnessy","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.01.031_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1053\/j.ajkd.2021.10.004","article-title":"Quantification of glomerular structural lesions: associations with clinical outcomes and transcriptomic profiles in nephrotic syndrome","volume":"79","author":"Hodgin","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2023.01.031_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2215\/CJN.02560315","article-title":"Complete remission in the nephrotic syndrome study network","volume":"11","author":"Gipson","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.01.031_bib4","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1172\/JCI85939","article-title":"Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury","volume":"126","author":"Pedigo","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2023.01.031_bib5","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.2337\/db13-0399","article-title":"Cyclodextrin protects podocytes in diabetic kidney disease","volume":"62","author":"Merscher-Gomez","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.ekir.2023.01.031_bib6","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1172\/JCI125316","article-title":"ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes","volume":"129","author":"Ducasa","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2023.01.031_bib7","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.kint.2018.06.031","article-title":"Hydroxypropyl-\u03b2-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis","volume":"94","author":"Mitrofanova","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.01.031_bib8","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1194\/jlr.M300451-JLR200","article-title":"Characterization of apoM in normal and genetically modified mice","volume":"45","author":"Faber","year":"2004","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.ekir.2023.01.031_bib9","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1194\/jlr.M600055-JLR200","article-title":"Isolation and characterization of human apolipoprotein M-containing lipoproteins","volume":"47","author":"Christoffersen","year":"2006","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.ekir.2023.01.031_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nm1211","article-title":"Apolipoprotein M is required for pre\u03b2-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis","volume":"11","author":"Wolfrum","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.ekir.2023.01.031_bib11","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.bbalip.2013.04.009","article-title":"Apolipoprotein M promotes mobilization of cellular cholesterol in\u00a0vivo","volume":"1831","author":"Els\u00f8e","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ekir.2023.01.031_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2011.11.031","article-title":"Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL","volume":"221","author":"Els\u00f8e","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2023.01.031_bib13","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1074\/jbc.M704576200","article-title":"Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice","volume":"283","author":"Christoffersen","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ekir.2023.01.031_bib14","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.1103187108","article-title":"Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M","volume":"108","author":"Christoffersen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ekir.2023.01.031_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-017-0429-2","article-title":"HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium","volume":"16","author":"Ruiz","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ekir.2023.01.031_bib16","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1096\/fj.201500064","article-title":"Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1","volume":"30","author":"Christensen","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.ekir.2023.01.031_bib17","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1172\/JCI89626","article-title":"Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency Find the latest version: mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency","volume":"127","author":"Lovric","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2023.01.031_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jbior.2018.09.004","article-title":"Sphingosine phosphate lyase insufficiency syndrome (SPLIS): a novel inborn error of sphingolipid metabolism","volume":"71","author":"Choi","year":"2019","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.ekir.2023.01.031_bib19","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1172\/JCI90171","article-title":"Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome","volume":"127","author":"Prasad","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2023.01.031_bib20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.2012.428","article-title":"Design of the nephrotic syndrome study network (Neptune) to evaluate primary glomerular nephropathy by a multidisciplinary approach","volume":"83","author":"Gadegbeku","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.01.031_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1523-1755.2002.00113.x","article-title":"Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application","volume":"61","author":"Cohen","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.01.031_bib22","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1194\/jlr.D055947","article-title":"Protein unfolding allows use of commercial antibodies in an apolipoprotein M sandwich ELISA","volume":"56","author":"Bosteen","year":"2015","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.ekir.2023.01.031_bib23","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1194\/jlr.M700113-JLR200","article-title":"An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma","volume":"48","author":"Axler","year":"2007","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.ekir.2023.01.031_bib24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.atherosclerosis.2018.06.815","article-title":"Apolipoprotein M in patients with chronic kidney disease","volume":"275","author":"S\u00f8rensen","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2023.01.031_bib25","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.kint.2020.10.047","article-title":"Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease","volume":"99","author":"Pierce","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.01.031_bib26","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C\u2013based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2023.01.031_bib27","doi-asserted-by":"crossref","first-page":"31286","DOI":"10.1074\/jbc.274.44.31286","article-title":"A\u00a0novel human apolipoprotein (apoM)","volume":"274","author":"Xu","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ekir.2023.01.031_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1078\/0065-1281-00687","article-title":"Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization","volume":"105","author":"Zhang","year":"2003","journal-title":"Acta Histochem"},{"issue":"6220","key":"10.1016\/j.ekir.2023.01.031_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.ekir.2023.01.031_bib30","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1096\/fj.201801748R","article-title":"Apolipoprotein M suppresses the phenotypes of IgA nephropathy in hyper-IgA mice","volume":"33","author":"Kurano","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.ekir.2023.01.031_bib31","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1055\/s-0038-1641750","article-title":"Apolipoprotein M protects lipopolysaccharide-treated mice from death and organ injury","volume":"118","author":"Kurano","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ekir.2023.01.031_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2007.10.007","article-title":"Infection and inflammation decrease apolipoprotein M expression","volume":"199","author":"Feingold","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2023.01.031_bib33","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/cc11305","article-title":"Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes","volume":"16","author":"Kumaraswamy","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.ekir.2023.01.031_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-019-1890-2","article-title":"Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus","volume":"21","author":"Tyd\u00e9n","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ekir.2023.01.031_bib35","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1194\/jlr.P089409","article-title":"Plasma apoM and S1P levels are inversely associated with mortality in African Americans with type 2 diabetes mellitus","volume":"60","author":"Liu","year":"2019","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.ekir.2023.01.031_bib36","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.119.045323","article-title":"Reduced apolipoprotein M and adverse outcomes across the spectrum of human heart failure","volume":"141","author":"Chirinos","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2023.01.031_bib37","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2796.2009.02095.x","article-title":"Apolipoprotein M predicts pre-\u03b2-HDL formation: studies in type 2 diabetic and nondiabetic subjects","volume":"266","author":"Plomgaard","year":"2009","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.ekir.2023.01.031_bib38","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.numecd.2014.05.007","article-title":"The association between apolipoprotein M and insulin resistance varies with country of birth","volume":"24","author":"Memon","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.ekir.2023.01.031_bib39","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/db19-0811","article-title":"Protection against insulin resistance by apolipoprotein M\/sphingosine-1-phosphate","volume":"69","author":"Kurano","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.ekir.2023.01.031_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinbiochem.2008.10.008","article-title":"Apolipoprotein M promoter polymorphisms alter promoter activity and confer the susceptibility to the development of type 1 diabetes","volume":"42","author":"Wu","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ekir.2023.01.031_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/dmrr.641","article-title":"Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese","volume":"23","author":"Niu","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.ekir.2023.01.031_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12866","article-title":"High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate","volume":"48","author":"Brinck","year":"2018","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.ekir.2023.01.031_bib43","first-page":"1","article-title":"The apoM\/S1P complex\u2014A mediator in kidney biology and disease?","volume":"8","author":"Bisgaard","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ekir.2023.01.031_bib44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1210\/me.2005-0209","article-title":"Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M","volume":"20","author":"Faber","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ekir.2023.01.031_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2017.01.006","article-title":"ApoM\/HDL-C and apoM\/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus","volume":"466","author":"Zhang","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ekir.2023.01.031_bib46","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.clinbiochem.2015.08.001","article-title":"The effect of nephropathy on plasma sphingosine 1-phosphate concentrations in patients with type 2 diabetes","volume":"48","author":"Bekpinar","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ekir.2023.01.031_bib47","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.kint.2022.10.023","article-title":"Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis","volume":"103","author":"Mariani","year":"2023","journal-title":"Kidney Int"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024923000402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024923000402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:42:53Z","timestamp":1762832573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024923000402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2468024923000402"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2023.01.031","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Glomerular and Plasma Apolipoprotein M as Novel Biomarkers in Glomerular Disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2023.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}